Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.

Liu Y, Banka S, Huang Y, Hardman-Smart J, Pye D, Torrelo A, Beaman GM, Kazanietz MG, Baker MJ, Ferrazzano C, Shi C, Orozco G, Eyre S, van Geel M, Bygum A, Fischer J, Miedzybrodzka Z, Abuzahra F, Rübben A, Cuvertino S, Ellingford JM, Smith MJ, Evans DG, Weppner-Parren LJMT, van Steensel MAM, Chaudhary IH, Mangham DC, Lear JT, Paus R, Frank J, Newman WG, Zhang X

Open source

DOI: 10.1111/bjd.21842
Published: 2022 Dec
Container: The British journal of dermatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjd.21842,
  title = {Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.},
  author = {Liu Y and Banka S and Huang Y and Hardman-Smart J and Pye D and Torrelo A and Beaman GM and Kazanietz MG and Baker MJ and Ferrazzano C and Shi C and Orozco G and Eyre S and van Geel M and Bygum A and Fischer J and Miedzybrodzka Z and Abuzahra F and Rübben A and Cuvertino S and Ellingford JM and Smith MJ and Evans DG and Weppner-Parren LJMT and van Steensel MAM and Chaudhary IH and Mangham DC and Lear JT and Paus R and Frank J and Newman WG and Zhang X},
  year = {2022},
  journal = {The British journal of dermatology},
  doi = {10.1111/bjd.21842},
  url = {https://doi.org/10.1111/bjd.21842}
}

RIS

TY  - JOUR
TI  - Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.
AU  - Liu Y
AU  - Banka S
AU  - Huang Y
AU  - Hardman-Smart J
AU  - Pye D
AU  - Torrelo A
AU  - Beaman GM
AU  - Kazanietz MG
AU  - Baker MJ
AU  - Ferrazzano C
AU  - Shi C
AU  - Orozco G
AU  - Eyre S
AU  - van Geel M
AU  - Bygum A
AU  - Fischer J
AU  - Miedzybrodzka Z
AU  - Abuzahra F
AU  - Rübben A
AU  - Cuvertino S
AU  - Ellingford JM
AU  - Smith MJ
AU  - Evans DG
AU  - Weppner-Parren LJMT
AU  - van Steensel MAM
AU  - Chaudhary IH
AU  - Mangham DC
AU  - Lear JT
AU  - Paus R
AU  - Frank J
AU  - Newman WG
AU  - Zhang X
PY  - 2022
JO  - The British journal of dermatology
DO  - 10.1111/bjd.21842
UR  - https://doi.org/10.1111/bjd.21842
ER  -

APA

Y, L., S, B., Y, H., J, H., D, P., A, T., GM, B., MG, K., MJ, B., C, F., C, S., G, O., S, E., M, V. G., A, B., J, F., Z, M., F, A., A, R., S, C., JM, E., MJ, S., DG, E., LJMT, W., MAM, V. S., IH, C., DC, M., JT, L., R, P., J, F., WG, N., & X, Z. (2022). Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.. The British journal of dermatology. https://doi.org/10.1111/bjd.21842

Source records

pubmed · retrieved 2026-09-26T08:50:51.889Z